RAPID Impacting Healthcare Worldwide
Learn more >
iSchemaView Names Don Listwin CEO
Silicon Valley Leader Joins Stroke Care Revolution
Learn more >
The most advanced imaging technology at your fingertips
CT and MR compatible
FDA-cleared
CE mark
Fully automated with unparalleled speed and accessibility
The most accurate brain imaging software
RAPID was superior
Independent clinical study
Stroke, 2016
Fast and simple thresholding

April 24, 2018

Press Release

iSchemaView Technology RAPIDly Adopted by Over 350 Stroke Centers RAPID Becoming a New Standard in Advanced Cerebrovascular Imaging

iSchemaView, the leader in cerebrovascular imaging analysis, today announced accelerating adoption of its platform.

Read more

April 16, 2018

Press Release

iSchemaView Names Don Listwin as CEO Silicon Valley Leader Joins Innovator in Cerebrovascular Imaging to Revolutionize Stroke Care

iSchemaView, the leader in cerebrovascular imaging analysis, today announced that former Cisco and Openwave Systems executive, Don Listwin, has joined the company as Chief Executive Officer (CEO).

Read more

January 24, 2018

NBC News

New stroke guidelines extend time frame for life-saving treatment

New guidelines on treating stroke suggest that more people could be eligible for life-saving clot removal and treatments, expanding the "golden window" when doctors can minimize or prevent permanent damage from six to 24 hours.

Read More

January 24, 2018

AHA Stroke Journal

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

These guidelines detail prehospital care, urgent and emergency evaluation and treatment with intravenous and intra-arterial therapies, and in-hospital management, including secondary prevention measures that are appropriately instituted within the first 2 weeks.

Read More

January 24, 2018

ISC conference presentation

DEFUSE 3 Presentation at the Jan. 24 2018 International Stroke Conference in Los Angeles

DEFUSE 3, a 38-center clinical trial sponsored by the National Institutes of Health and led by Stanford researchers, has shown that far more people than previously thought can benefit from existing emergency treatments for acute ischemic stroke.

View Presentation

January 24, 2018

The Washington Post

New research will radically change response to strokes

Advanced brain imaging technology may give doctors an additional 10 hours or more to respond to some strokes, researchers said Wednesday, a development that may soon bring major changes to the way hospitals treat one of the leading causes of disability and death.

Read More